Journals / Romatizma Dergisi / 2008 / Cilt: 23 - Sayı: 3

Novel diagnostic autoantibodies in rheumatoid arthritis

Romatoid artrit'te yeni tanısal otoantikorlar

Pages
97–99
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The autoantibodies which probably play an importanat role in the pathogenesis of RA and have increasingly been examined in recent years, will be reviewed, discussed, and examples given of the work done.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Early diagnosis and early treatment can prevent joint damage in rheumatoid arthritis (RA); but the lack of appropriate diagnostic criteria hinders early diagnosis.
📊
Key Findings & Data:There are not many disease-specific serological markers for the diagnosis of the disease.
💡
Conclusion & Impact:The autoantibodies which probably play an importanat role in the pathogenesis of RA and have increasingly been examined in recent years, will be reviewed, discussed, and examples given of the work done.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Artrit · romatoid · Otoantikorlar

Abstract

Early diagnosis and early treatment can prevent joint damage in rheumatoid arthritis (RA); but the lack of appropriate diagnostic criteria hinders early diagnosis. There are not many disease-specific serological markers for the diagnosis of the disease. Highly sensitive and specific markers are needed in the early stages of the disease. The autoantibodies which probably play an importanat role in the pathogenesis of RA and have increasingly been examined in recent years, will be reviewed, discussed, and examples given of the work done.

Özet

Romatoid artritte (RA) erken tanı ve erken tedavi eklem hasarını önleyebilir; ancak uygun tanısal kriterlerin yetersiz olması erken tanıya engel olmaktadır. RA'te tanı konmakta yaşanan güçlükler, gerçek bir hastalığa-spesifik serolojik marker olmamasına bağlı olabilmektedir. Hastalık tanısı için erken döneminde kullanılabilecek, sensitivitesi ve spesifitesi yüksek serolojik testlere ihtiyaç vardır. Bu derlemede RA hastalığında rol oynaması muhtemel olan ve son yıllarda daha sıklıkla incelenmeye başlanan otoantikorlar kısaca tartışılacak ve yapılmış çalışmalardan örnekler sunulacaktır.

🔖

Cite This Article

YANIK, B., KÜLCÜ, D. G. (2008). Novel diagnostic autoantibodies in rheumatoid arthritis. Romatizma Dergisi, Cilt: 23 - Sayı: 3, 97–99. https://ajindex.com/articles/305896

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Steiner G, Smolen JS. Novel autoantibodies for the diagnosis of rheumatoid arthritis. Z Rheumatol. 2002; 61(6): 667-73
  2. Staikova ND, Kuzmanova SI, Solakov PT. Serologic markers of early rheumatoid arthritis. Folia Med (Plovdiv). 2003; 45(3): 35-42
  3. Steiner G, Smolen J. Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res. 2002; 4 Suppl 2: S1-5
  4. Smolen JS, Steiner G. Are autoantibodies active players or epiphenomena? Curr Opin Rheumatol. 1998; 10(3): 201-6
  5. Hueber W, Hassfeld W, Smolen JS, Steiner G. Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis. Rheumatology (Oxford).1999; 38(2): 155-9
  6. Hayem G, Chazerain P, Combe B, Elias A, Haim T, Nicaise P, et al. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol. 1999; 26(1): 7-13
  7. Després N, Boire G, Lopez-Longo FJ, Ménard HA. The Sa system: a novel antigen- antibody system specific for rheumatoid arthritis. J Rheumatol. 1994; 21(6): 1027-33
  8. Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis. 2005; 64(12): 1731-6
  9. Cordonnier C, Meyer O, Palazzo E, de Bandt M, Elias A, Nicaise P, et al. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol. 1996; 35(7): 620-4
  10. Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS. Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis. Br J Rheumatol. 1993; 32(3): 199-203
  11. De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis. 2004; 63(12): 1587-93
  12. Sibilia J. Autoantibodies, diagnostic and prognostic markers of rheumatoid polyarthritis. Presse Med. 2000 21; 29(31): 1723-30. 13. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 2002; 4(2): 87-93 14. Gupta B, Raghav SK, Agrawal C, Chaturvedi VP, Das RH, Das HR. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clin